Results 121 to 130 of about 76,292 (274)

Colistin for lung infection: an update [PDF]

open access: yesJournal of Intensive Care, 2015
Increasing incidence of resistance of gram-negative bacteria against even newer antibiotic including carbapenem has generated interest in the old antibiotic colistin, which are being used as salvage therapy in the treatment of multidrug resistant infection. Colistin has excellent bactericidal activity against most gram-negative bacilli.
openaire   +3 more sources

Outer membrane permeability of mcr-positive bacteria reveals potent synergy of colistin and macromolecular antibiotics against colistin-resistant Acinetobacter baumannii

open access: yesFrontiers in Microbiology
Colistin (CT) is the last-resort of antibiotic against multidrug-resistance (MDR) Acinetobacter baumannii (A. baumannii) infection. However, colistin resistance is increasingly reported in A.
Meisong Li   +26 more
doaj   +1 more source

Resistencia a colistina mediada por plásmido en Escherichia coli recuperadas de aves de corral sanas [PDF]

open access: yes, 2017
Resistencia a colistina mediada por plásmido en Escherichia coli recuperadas de aves de corral sanas.Fil: Dominguez, Johana Elizabeth. Consejo Nacional de Investigaciones Científicas y Técnicas.
Cejas, Daniela   +7 more
core   +1 more source

Comprehensive insights into colistin and colistin resistance: updated regulations and policies on colistin usage and alternative strategies for mitigation and prevention of colistin resistance

open access: yesNovel Research in Microbiology Journal
The increase in antimicrobial resistance (AMR) has a significant impact on healthcare, leading to longer hospital stays and higher economic costs. This is primarily caused by the over and inappropriate use of antibiotics. Microorganisms have developed various mechanisms to combat the effects of antibiotics, including modifying their genetic material to
Zine El abidine Bzazou El Ouazzani   +4 more
openaire   +2 more sources

Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis

open access: yesJournal of Infection and Public Health
Background: Carbapenem-resistant Enterobacteriaceae (CRE) infections pose a significant threat to global health due to limited treatment options and high mortality rates.
Wasan Katip   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy